Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per

At September 30, 2020 and 2019, the Company had the following common shares underlying these instruments:

 

    September 30,  
    2020     2019  
Warrants     1,845,722       362,061  
Preferred Stock Warrants     260,089       -  
Stock Options     610,229       125,103  
Preferred Stock     227,695       -  
Convertible Note Payable     -       2,500  
                 
Total Underlying Common Shares     2,943,735       489,664  
Schedule of Earnings Per Share, Basic and Diluted

The following data shows the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2020 and 2019:

 

    Three Months Ended September 30    

Nine Months Ended

September 30

 
    2020     2019     2020     2019  
                         
Net Loss per Common Share - Basic and Diluted   $ (0.42 )   $ (1.20 )   $ (1.74 )   $ (4.30 )
Loss from continuing                                
Operations available to Common stockholders (numerator)   $ (1,955,357 )   $ (1,600,794 )   $ (5,455,707 )   $ (4,678,397 )
                                 
Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)     4,675,749       1,285,160       3,137,459       1,099,627